Furthermore, increased QKI expression in tumor endothelial cells (TECs) was associated with significantly worse overall survival in lung cancer patients, suggesting QKI may be a clinically relevant therapeutic target to regulate tumor angiogenesis [36]. The gene discussed is QKI; the disease is neoplasm.